QR-Code

Recent advances in targeting LRRK2 for Parkinson’s disease treatment

Abstract Parkinson’s disease (PD) is a neurodegenerative disease with severe movement problems. Current treatments mainly focus on symptom management by reducing dopaminergic pathways in the brain. Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approac...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2025-07-01
Schriftenreihe:Journal of Translational Medicine
Schlagworte:
Parkinson’s disease
LRRK2
Neurodegenerative diseases
Autophagy
PROTAC
Mitochondrial dysfunction
Online-Zugang:https://doi.org/10.1186/s12967-025-06354-0
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge